He’s not a personal trainer, but University of Vermont Associate Professor of Medicine Michael Toth, Ph.D., has an idea for counteracting the muscle loss that commonly occurs in cancer patients. What causes this loss in muscle loss – or atrophy – with cancer and its treatment is still not known, but Toth believes that the reduction in physical activity during cancer treatment may be an important factor.

The University of Vermont Cancer Center’s annual Clinical and Translational Research Symposium took place on Friday, April 29, 2016 in the UVM Medical Center’s Davis Auditorium and provided a day of learning and scientific collaboration on the topic of “Thrombosis, Hemostasis, and Cancer.” Experts from across North America joined UVM Cancer Center members and colleagues to discuss the science of bleeding, blood clots, and related complications in cancer care.

The University of Vermont Cancer Center presented two events at the College of Medicine on June 23 and June 24 to highlight important research and information relating to men’s health and cancer.

While better technology and screening practices have led to the detection of more breast cancers in women—many of which fall into a broad category of early-stage cancer, including ductal carcinoma in situ or DCIS—researchers still do not understand why some of these early cancers remain idle, while others progress. With the support of a new, $3.7 million federal grant from the National Cancer Institute (NCI), an interdisciplinary team of researchers at the University of Vermont (UVM) Cancer Center will be looking to answer this question.

Full story >>